Head-to-head · Value Score
CoreAge Rx vs Gimme Care
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Gimme Care a 84. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameGimme Care
#34 · Grade B+ · Good Value
Est. first month
$160/mo month-to-month ($130/mo on a 3-month plan)
Save ~88% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 84 — an est. $99/mo first month, with no teaser step-up baked in. Gimme Care isn't out of it: People who want to compare a monthly rate against a quarterly one on the same screen, and who will commit to three months if they want the lower figure.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Gimme Care |
|---|---|---|
| Value Score | 93 (A+) | 84 (B+) |
| Est. first month | $99/mo | $160/mo month-to-month ($130/mo on a 3-month plan) |
| Save vs brand-name | ~89% | ~88% |
| Semaglutide | $99/mo | $160/mo month-to-month ($130/mo on a 3-month plan) |
| Tirzepatide | $149/mo | $199/mo month-to-month ($163/mo on a 3-month plan) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Gimme Care
One of the few programs that shows you the billing cycle beside the price instead of behind it - though the numbers it leads with, $130 and $163, are the three-month rates rather than what a monthly patient pays.
Why it's a deal
- Publishes a billing-cycle table, so the one-month and three-month rates sit side by side rather than one hiding the other
- Both molecules are priced on the same page, with the same cycle choices
- Available in all 50 states
- Also lists sermorelin and NAD+ openly, so you can see what else would be billed if you added it
The fine print
- The headline $130 and $163 are three-month rates - month to month costs $160 and $199
- Compounded only, with no brand-name option
- No oral or sublingual route
- The cheaper cycle means paying a quarter up front, so leaving early costs more than one month
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Gimme Care.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.